Exagen
41 hedge funds and large institutions have $25.1M invested in Exagen in 2024 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 14 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
43% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 14
81% less call options, than puts
Call options by funds: $5K | Put options by funds: $26K
Holders
41
Holding in Top 10
–
Calls
$5K
Puts
$26K
Top Buyers
| 1 | +$3.21M | |
| 2 | +$1.51M | |
| 3 | +$57.8K | |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$53.8K |
| 5 |
VF
Virtu Financial
New York
|
+$40.4K |
Top Sellers
| 1 | -$1.61M | |
| 2 | -$1.02M | |
| 3 | -$127K | |
| 4 |
Renaissance Technologies
New York
|
-$72.3K |
| 5 |
PM
Penbrook Management
New York
|
-$66.2K |